Preliminary Efficacy and Safety Data from the Phase 2 Trial of Riliprubart (SAR445088), a Humanized Monoclonal Antibody Targeting Complement C1s, in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (S15.008)

Abstract only

Saved in:
Bibliographic Details
Published in:Neurology Vol. 102; no. 17_supplement_1
Main Authors: Querol, Luis, Lewis, Richard, Hartung, Hans-Peter, Van Doorn, Pieter, Wallstroem, Erik, Luo, Xiaodong, Alonso, Miguel Alonso, Atassi, Nazem, Hughes, Richard
Format: Journal Article
Language:English
Published: 09-04-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract only
AbstractList Abstract only
Author Wallstroem, Erik
Alonso, Miguel Alonso
Hughes, Richard
Atassi, Nazem
Luo, Xiaodong
Van Doorn, Pieter
Querol, Luis
Lewis, Richard
Hartung, Hans-Peter
Author_xml – sequence: 1
  givenname: Luis
  surname: Querol
  fullname: Querol, Luis
  organization: Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau
– sequence: 2
  givenname: Richard
  surname: Lewis
  fullname: Lewis, Richard
  organization: Cedars Sinai Medical Center
– sequence: 3
  givenname: Hans-Peter
  surname: Hartung
  fullname: Hartung, Hans-Peter
  organization: Department of Neurology, Faculty of Medicine, Heinrich Heine University
– sequence: 4
  givenname: Pieter
  surname: Van Doorn
  fullname: Van Doorn, Pieter
  organization: Erasmus MC, University Medical Center
– sequence: 5
  givenname: Erik
  surname: Wallstroem
  fullname: Wallstroem, Erik
  organization: Sanofi R&D, Neurology Development
– sequence: 6
  givenname: Xiaodong
  surname: Luo
  fullname: Luo, Xiaodong
  organization: Sanofi R&D, Biostatistics and Programming
– sequence: 7
  givenname: Miguel Alonso
  surname: Alonso
  fullname: Alonso, Miguel Alonso
  organization: Sanofi R&D, Neurology Development
– sequence: 8
  givenname: Nazem
  surname: Atassi
  fullname: Atassi, Nazem
  organization: Sanofi R&D, Neurology Development
– sequence: 9
  givenname: Richard
  surname: Hughes
  fullname: Hughes, Richard
  organization: UCL Queen Square Institute of Neurology, University College London
BookMark eNqdkMFKw0AQhhepYKu-gYc5ttDWJE3a9FjSSgsqoS3oLUzT3WZldzZstof4or6Oq4gHj85lYH4--OfrsQ4Z4ozdhcE4jMLo_uX5cRz8ThTEyXx6wbphEk1H00n02mFdf05Hk3SWXrFe07wFgQ9n8y77yC1XUktC28JKCFli2QLSEXYouGthiQ5BWKPBVRzyChsOEeytRAVGwFYqWdvzAa2D_m6xjeMkSNPBEBDWZ40k3_kRngyZUhnyyIKcPJhjC3u0J-4knSAzulZcc3KQhc0QJEFWWUOyhA0JhVqjM77dkuvWdyX8pnKjWuJna2p0VQv9bLPMB75CmHgV6eCGXQpUDb_92dcsfljts_WotKZpLBdFbaX2TxdhUHxJLLzE4q_EyT-xT5difJg
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1212/WNL.0000000000204596
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
ExternalDocumentID 10_1212_WNL_0000000000204596
GroupedDBID ---
-~X
.XZ
.Z2
01R
0R~
123
1J1
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAWTL
AAXQO
AAYEP
AAYXX
ABBLC
ABIVO
ABJNI
ABOCM
ABVCZ
ACDDN
ACGFS
ACILI
ACLDA
ACOAL
ACWRI
ACXJB
ADGGA
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFUWQ
AGINI
AHOMT
AHQNM
AHVBC
AIJEX
AKULP
AKWKN
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BYPQX
C45
CITATION
CS3
DIWNM
DU5
E.X
EBS
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GQDEL
HZ~
IKYAY
IN~
IPNFZ
JF7
KD2
KMI
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHYEH
OJAPA
OL1
OLB
OLH
OLU
OLV
OLW
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RHI
RIG
RLZ
RXW
SJN
TEORI
V2I
VVN
W3M
WH7
WOQ
WOW
XSW
XXN
XYM
XYN
YBU
YCJ
YFH
~9M
ID FETCH-crossref_primary_10_1212_WNL_00000000002045963
ISSN 0028-3878
IngestDate Wed Nov 27 12:57:00 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 17_supplement_1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-crossref_primary_10_1212_WNL_00000000002045963
ParticipantIDs crossref_primary_10_1212_WNL_0000000000204596
PublicationCentury 2000
PublicationDate 2024-04-09
PublicationDateYYYYMMDD 2024-04-09
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-09
  day: 09
PublicationDecade 2020
PublicationTitle Neurology
PublicationYear 2024
SSID ssj0015279
Score 4.988787
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
Title Preliminary Efficacy and Safety Data from the Phase 2 Trial of Riliprubart (SAR445088), a Humanized Monoclonal Antibody Targeting Complement C1s, in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (S15.008)
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ3fi9NAEMeX6wnii_gTfzMPCld6wWaTa5rH0lSq1BJtUd_CtrvhIr1Ecg1S_1H_HWd286tHEftgH0JJ0yXJfJjdnZ39DmOvpeTSduK-JSnG5OIMzBLo9Swu10Ko1UrYWq5puvDm34bBxJ2cdKqSfs25_2ppPIe2pp2zR1i7bhRP4He0OR7R6nj8J7uHudroSl35jsomow3WRmJpIWJKzwzEVjSbSsJL7MV6vLfUxTtImITiK3lB6_w0-FyMPrsuja7ecF8nepqof_ILx6noDrL1RkcSR-k2WWVy11vqxPIql8CkpvfGtoaF9hcaKV70SjGSeGVW-AN1taNd8UL_L8w2Oy2ySbWSdSrC-H0Q6uAF3o5NsalhFb74XklP4eXt1YFPhcpN5bBZkdSThpn6aQQVWmICxvnm29LlTbHjtvZSlr-g_wuyzKQ8h0n9Uxko4Sa_xm87fz4kKWHj7lXp7_nAGji6onvTIfR5m3wvuqYCq_qNRfbBbgf7f-Ti63xm5DD1h3T-_QMq3zd63zonkmZj2E6ErUQ3W-mwWxwdKfnxxYd5vUp2wT2_UhmnByu3hmIrbw_dS2vo1RpDLe-xu-XkB0aG2vvsRKUP2O2PZXrHQ_a7BS9U8ALCCwZeIHiB4AWEFzS8wEHDC1kMLXjhrEa3ew4CamyhwRYqbKHGFhpsAbE9hySFElpoQwt70MI-tHBGyHbxFgyu3UfMfTdZjqdW9WKiH0bkJfqbOZzH7DTNUvWEQezFF0NP-d66H7srGfuxkK47QC-3ctyBI5-y45p-duT1z9mdhvUX7HSbF-ol61zL4pVm5Q9st7oZ
link.rule.ids 315,782,786,27933,27934
linkProvider Multiple Vendors
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preliminary+Efficacy+and+Safety+Data+from+the+Phase+2+Trial+of+Riliprubart+%28SAR445088%29%2C+a+Humanized+Monoclonal+Antibody+Targeting+Complement+C1s%2C+in+Chronic+Inflammatory+Demyelinating+Polyneuropathy+%28CIDP%29+%28S15.008%29&rft.jtitle=Neurology&rft.au=Querol%2C+Luis&rft.au=Lewis%2C+Richard&rft.au=Hartung%2C+Hans-Peter&rft.au=Van+Doorn%2C+Pieter&rft.date=2024-04-09&rft.issn=0028-3878&rft.eissn=1526-632X&rft.volume=102&rft.issue=17_supplement_1&rft_id=info:doi/10.1212%2FWNL.0000000000204596&rft.externalDBID=n%2Fa&rft.externalDocID=10_1212_WNL_0000000000204596
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-3878&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-3878&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-3878&client=summon